JPRN-UMIN000001227已完成1 期
Phase I/II trial of Nedaplatin and Docetaxel for advanced Squamous cell carcinoma of the lung - Phase I/II trial of Nedaplatin and Docetaxel for advanced Squamous cell carcinoma of the lung
ational Cancer Center Hospital East Thoracic Oncology Division0 个研究点目标入组 24 人开始时间: 2008年7月7日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
Thirteen patients (62%) out of 21 responded to nedaplatin and docetaxel. Median progression-free survival was 7.4 months (95% CI 3.5 – 11.4 months).
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Pre-existing pulmonary fibrosis (chest Xray) 2)Previous history of another cancer 3)Uncontrolled comorbidities 4)Active infection 5)Pregnancy or lactation 6)Symptomatic brain metastases 7)Allergy to polysorbate 80 8)Considered unfit for trial by own physician
研究者
相似试验
招募中
2 期
The Phase II Study of Docetaxel plus Nedaplatin as Adjuvant Chemotherapy in Patients with Completely Resected Stage IB-IIIA Non-Small Cell Lung Canceron-small cell lung cancerJPRN-UMIN000004634Shiga University of Medical Science30
已完成
1 期
Phase I/II study of biweekly docetaxel, cisplatin, and S-1 combination neoadjuvant chemotherapy in patients with stage III gastric cancergastric cancerJPRN-UMIN000011625Yokohama City University Medical Center51
已完成
2 期
Multicenter phase II study of docetaxel/cisplatin/bevacizumab combination therapy in patients with advanced non-squamous non-small cell lung cancer (TORG1016)JPRN-UMIN000004368Thoracic Oncology Research Group47
招募中
2 期
Phase II trial of docetaxel (T), cisplatin (P) and fluorouracil (5-FU) in the treatment of metastatic penile cancerpatients with metastatic penile cancerJPRN-UMIN000002697Fudan University Shanghai Cancer Center40
招募中
2 期
Phase II study of nedaplatin plus docetaxel in patients with advanced squamous cell lung cancer pretreated with platinum-based chemotherapy.relapsed squamous cell lung cancerJPRN-UMIN000003883Shizuoka Cancer Center, Thoracic Oncology Division28